Literature DB >> 1675783

Effects of spinal kappa-opioid receptor agonists on the responsiveness of nociceptive superficial dorsal horn neurons.

Janice L K Hylden1, Richard L Nahin, Richard J Traub, Ronald Dubner.   

Abstract

Spinal cord application of the kappa-opioid receptor agonists dynorphin (50 nmol) or (1S,2S)U-50,488H (0.19-1.9 mumol) produced changes in the excitability of some superficial dorsal horn nociceptive neurons. One-third of the cells exhibited expansion of their receptive fields as defined using mechanical stimuli following a spinal kappa agonist (dynorphin or U-50,488H); receptive field expansions were of the same order as those observed immediately after a conditioning electrical stimulus applied to a peripheral nerve. In addition, spinal U-50,488H produced changes in mechanical and thermal thresholds of the majority of superficial dorsal horn neurons. These changes were dose-dependent. Facilitation of responses occurred at lower doses and inhibition occurred primarily at higher doses, but these effects were not reversed by subsequent administration of naloxone. The data are consistent with the hypothesis that one action of increases in spinal dynorphin levels due to peripheral inflammation, tissue injury or nerve damage, is to contribute to enhanced neuronal excitability in superficial dorsal horn neurons.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675783     DOI: 10.1016/0304-3959(91)90136-L

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  11 in total

1.  Effects of peripheral and spinal κ-opioid receptor stimulation on the exercise pressor reflex in decerebrate rats.

Authors:  Steven W Copp; Audrey J Stone; Katsuya Yamauchi; Marc P Kaufman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-11       Impact factor: 3.619

Review 2.  Spinal opioid systems in inflammation.

Authors:  L Stanfa; A Dickenson
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

3.  Incisional Injury Modulates Morphine Reward and Morphine-Primed Reinstatement: A Role of Kappa Opioid Receptor Activation.

Authors:  Chinwe A Nwaneshiudu; Xiao-You Shi; J David Clark
Journal:  Anesth Analg       Date:  2020-01       Impact factor: 5.108

4.  ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity.

Authors:  Ru-Rong Ji; Katia Befort; Gary J Brenner; Clifford J Woolf
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

5.  Attenuation of cannabinoid-induced inhibition of medullary dorsal horn neurons by a kappa-opioid receptor antagonist.

Authors:  Akiko Okada-Ogawa; Masayuki Kurose; Ian D Meng
Journal:  Brain Res       Date:  2010-08-31       Impact factor: 3.252

6.  Antagonists of the kappa-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligation.

Authors:  I Obara; J Mika; M K-H Schafer; B Przewlocka
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

7.  Neuropeptide gene expression and capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in the rat.

Authors:  L F Donaldson; D S McQueen; J R Seckl
Journal:  J Physiol       Date:  1995-07-15       Impact factor: 5.182

8.  Neurotransmitters in the spinal cord dorsal horn in a model of painful neuropathy and in nerve crush.

Authors:  C Sommer; R R Myers
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.

Authors:  Joshua D Gross; Shane W Kaski; Karl T Schmidt; Elizabeth S Cogan; Kristen M Boyt; Kim Wix; Adam B Schroer; Zoe A McElligott; David P Siderovski; Vincent Setola
Journal:  Neuropsychopharmacology       Date:  2019-05-29       Impact factor: 7.853

10.  The Persistent Pain Transcriptome: Identification of Cells and Molecules Activated by Hyperalgesia.

Authors:  Matthew R Sapio; Jenny J Kim; Amelia J Loydpierson; Dragan Maric; Taichi Goto; Fernando A Vazquez; Mary K Dougherty; Radhika Narasimhan; Wallis T Muhly; Michael J Iadarola; Andrew J Mannes
Journal:  J Pain       Date:  2021-04-20       Impact factor: 5.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.